After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Xeris Biopharma Holdings Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Xeris Biopharma Holdings Inc is $1.15B. A total of 1.8 million shares were traded on the day, compared to an average of 2.43M shares.
In the most recent transaction, Hecht Beth sold 16,667 shares of XERS for 7.01 per share on Dec 01 ’25. After the transaction, the insider now owns 1,320,176 company shares. In a previous transaction on Nov 13 ’25, Shannon John Patrick Jr sold 23,242 shares at 7.46 per share. XERS shares that the insider owns now total 2,643,153.
Among the insiders who sold shares, Hecht Beth disposed of 16,667 shares on Nov 11 ’25 at a per-share price of $7.40. This resulted in the insider holding 1,336,843 shares of XERS after the transaction. In another insider transaction, JOHN SHANNON bought 48,149 shares at $7.59 per share on Nov 13 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, XERS has a high of $10.08 and a low of $3.14.
As of this writing, XERS has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.07 per share and a lower estimate of $0.02. The company reported an EPS of -$0.03 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. XERS’s latest balance sheet shows that the firm has $102.43M in Cash & Short Term Investments as of fiscal 2021. There were $88.07M in debt and $79.04M in liabilities at the time. Its Book Value Per Share was -$0.01, while its Total Shareholder’s Equity was $95.23M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XERS is Buy with a score of 4.50.
